Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walsh

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 casesKhalaf Kridin, Marie-Charlotte Brüggen, Sarah Walsh, et al.
The Lancet Regional Health. Europe|April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based studyKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
Science (New York, N.Y.)|May 15, 2025
Norepinephrine signals through astrocytes to modulate synapsesKatheryn B Lefton, Yifan Wu, Yanchao Dai, et al.
The British Journal of Dermatology|June 27, 2025
The impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: A mixed method systematic reviewPauline O'Reilly, Rajamanikandan Savarimalai, Sarah Walsh, et al.
British Journal of Clinical Pharmacology|July 30, 2021
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteersDisala Fernando, Richard Dimelow, Ciara Gorey, et al.
The British Journal of Dermatology|August 20, 2024
The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: an interpretative descriptive qualitative studyPauline O'Reilly, Sarah Walsh, Christopher B Bunker, et al.
Plos One|June 27, 2022
Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative reviewPauline O'Reilly, Pauline Meskell, Barbara Whelan, et al.
Scientific Reports|April 18, 2026
Non-severe burn injury leads to sustained molecular changes in the brain in a murine modelAmira Allahham, Nutan Chaudhari, Sarah Walsh, et al.
Frontiers in Immunology|September 19, 2025
Mesenchymal stromal cells as rescue therapy in biologic-refractory psoriasis: insights from a case seriesSu M Lwin, Shane Solanky, Cristiano Scottà, et al.
Journal of Medical Microbiology|March 18, 2021
Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samplesJamie L Thompson, Angela Downie Ruiz Velasco, Alice Cardall, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 casesKhalaf Kridin, Marie-Charlotte Brüggen, Sarah Walsh, et al.
The Lancet Regional Health. Europe|April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based studyKatie Bechman, Mark D Russell, Kathryn Biddle, et al.
Science (New York, N.Y.)|May 15, 2025
Norepinephrine signals through astrocytes to modulate synapsesKatheryn B Lefton, Yifan Wu, Yanchao Dai, et al.
The British Journal of Dermatology|June 27, 2025
The impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: A mixed method systematic reviewPauline O'Reilly, Rajamanikandan Savarimalai, Sarah Walsh, et al.
British Journal of Clinical Pharmacology|July 30, 2021
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteersDisala Fernando, Richard Dimelow, Ciara Gorey, et al.
The British Journal of Dermatology|August 20, 2024
The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: an interpretative descriptive qualitative studyPauline O'Reilly, Sarah Walsh, Christopher B Bunker, et al.
Plos One|June 27, 2022
Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative reviewPauline O'Reilly, Pauline Meskell, Barbara Whelan, et al.
Scientific Reports|April 18, 2026
Non-severe burn injury leads to sustained molecular changes in the brain in a murine modelAmira Allahham, Nutan Chaudhari, Sarah Walsh, et al.
Frontiers in Immunology|September 19, 2025
Mesenchymal stromal cells as rescue therapy in biologic-refractory psoriasis: insights from a case seriesSu M Lwin, Shane Solanky, Cristiano Scottà, et al.
Journal of Medical Microbiology|March 18, 2021
Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samplesJamie L Thompson, Angela Downie Ruiz Velasco, Alice Cardall, et al.
Pageof 9